Stericycle Inc. (NASDAQ:SRCL) – Equities research analysts at Oppenheimer Holdings decreased their FY2017 earnings per share (EPS) estimates for Stericycle in a note issued to investors on Monday. Oppenheimer Holdings analyst S. Schneeberger now forecasts that the firm will post earnings per share of $4.78 for the year, down from their previous forecast of $5.20.

A number of other research analysts have also recently commented on the company. Zacks Investment Research cut Stericycle from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Northcoast Research cut Stericycle from a “buy” rating to a “neutral” rating in a research note on Tuesday. RBC Capital Markets reaffirmed an “underperform” rating and set a $77.00 price objective (down from $89.00) on shares of Stericycle in a research note on Monday. Royal Bank Of Canada reduced their price objective on Stericycle from $89.00 to $77.00 and set an “underperform” rating on the stock in a research note on Monday. Finally, Imperial Capital reduced their price objective on Stericycle from $93.50 to $80.00 and set an “underperform” rating on the stock in a research note on Friday, September 9th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $110.32.

Shares of Stericycle (NASDAQ:SRCL) traded down 1.05% during mid-day trading on Tuesday, reaching $77.18. The company had a trading volume of 1,131,100 shares. Stericycle has a 12-month low of $76.90 and a 12-month high of $151.57. The company has a market capitalization of $6.56 billion, a P/E ratio of 27.17 and a beta of 0.27. The firm has a 50-day moving average of $85.11 and a 200-day moving average of $102.87.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/brokers-issue-forecasts-for-stericycle-inc-s-fy2017-earnings-srcl.html

Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting analysts’ consensus estimates of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The business earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. During the same period in the previous year, the company posted $1.14 EPS. The firm’s revenue was up 24.6% compared to the same quarter last year.

Several institutional investors have recently added to or reduced their stakes in SRCL. Parkside Financial Bank & Trust raised its position in Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock valued at $149,000 after buying an additional 41 shares during the last quarter. Genesee Valley Trust Co. raised its position in Stericycle by 1.0% in the second quarter. Genesee Valley Trust Co. now owns 4,511 shares of the company’s stock valued at $470,000 after buying an additional 43 shares during the last quarter. Spero Smith Investment Advisers Inc. OH raised its position in Stericycle by 0.3% in the second quarter. Spero Smith Investment Advisers Inc. OH now owns 16,883 shares of the company’s stock valued at $1,758,000 after buying an additional 50 shares during the last quarter. Ameritas Investment Partners Inc. raised its position in Stericycle by 1.7% in the second quarter. Ameritas Investment Partners Inc. now owns 3,091 shares of the company’s stock valued at $322,000 after buying an additional 53 shares during the last quarter. Finally, Mn Services Vermogensbeheer B.V. raised its position in Stericycle by 2.7% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 2,159 shares of the company’s stock valued at $202,000 after buying an additional 57 shares during the last quarter. Hedge funds and other institutional investors own 92.81% of the company’s stock.

In other news, Director Rodney F. Dammeyer sold 10,188 shares of Stericycle stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $85.50, for a total transaction of $871,074.00. Following the completion of the transaction, the director now directly owns 10,188 shares in the company, valued at $871,074. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction that occurred on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total transaction of $114,426.30. Following the transaction, the executive vice president now owns 1,088 shares of the company’s stock, valued at $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by company insiders.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.